Safety of pembrolizumab (pem) in patients (pts) who stopped ipilimumab (ipi) due to immune-related adverse events. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
Survival analysis of multivariate failure time data addresses the statistical modelling of multiple related event times observed on the same experimental unit or within clusters. Such data arise in ...
Existing data on the prognosis and clinicopathological features of patients with metastatic renal cell carcinoma (mRCC) are limited. This study aims to investigate the prognostic value and ...
A retrospective analysis compared the overall survival outcomes for SIRT and PHP in patients with metastatic uveal melanoma.
Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study. Background: In the absence of curative treatment for the ...